Resveratrol and 1,25-dihydroxyvitamin D decrease Lingo-1 levels, and improve behavior in harmaline-induced Essential...

Area of Science:

• Neuroscience
• Genetics
• Pharmacology

Background:

• Essential tremor (ET) is a neurological disorder impacting motor and cognitive functions.
• Increased cerebellar Lingo-1 expression is linked to higher ET risk and neurodegeneration.
• Sirt1 protein offers neuroprotection in ET, and its activity is enhanced by Resveratrol (Res) and 1,25-dihydroxyvitamin D3 (VitD3).

Purpose of the Study:

• To investigate the neuroprotective effects of combined Resveratrol and Vitamin D3 treatment in a rat model of essential tremor.
• To determine if co-treatment modulates Sirt1 and Lingo-1 gene expression levels.
• To assess the impact of combined Res-VitD3 on ET-related motor and cognitive deficits.

Main Methods:

• A harmaline injection model was used to induce ET-like symptoms in adult rats.
• Rats received daily intraperitoneal injections of Resveratrol (5 mg/kg) and Vitamin D3 (0.1 mg/kg) before harmaline exposure.
• Quantitative PCR (qPCR) was used to measure Sirt1 and Lingo-1 gene expression levels.

Main Results:

• Harmaline exposure impaired motor coordination, increased tremors, and caused cognitive dysfunction.
• Combined Res-VitD3 treatment significantly reduced tremor severity, rearing, and memory impairment.
• Co-treatment modulated Sirt1 and Lingo-1 gene expression, with beneficial behavioral effects not observed with individual treatments.

Conclusions:

• Combined Resveratrol and Vitamin D3 treatment effectively improved locomotor and cognitive deficits in an ET model.
• The synergistic effects of Res-VitD3 appear to be mediated through modulation of Sirt1 and Lingo-1 pathways.
• Co-administration of Resveratrol and Vitamin D3 is recommended for managing essential tremor symptoms due to their complementary neuroprotective actions.